Table of Contents Table of Contents
Previous Page  289 / 1851 Next Page
Information
Show Menu
Previous Page 289 / 1851 Next Page
Page Background

Scope trial: update

Exclusive RT-CT

(contemporary series)

3-yr OS: 47.2%

Prognostic factors:

- Radiation dose

- Cisplatin intensity

Crosby, BJC, 2017, 116: 709-716

1 … 284 285 286 287 288 289 290 291 292 293 294 295 … 1851  FlippingBook